Hypera Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

HYPERA S.A. A Publicly-Held Corporation CNPJ/MF No. 02.932.074/0001-91 NIRE 35.300.353.251 CVM...

For more than 100 years, it has been believed that sunlight and vitamin D deficiency were associated with the risk for many deadly cancers including colorectal, prostate and breast. But some scientists remained skeptical that this nutrient provides any benefit for reducing cancer risk and morbidity and mortality and several randomized controlled trials that have supported this doubt. However, in a new commentary in JAMA Network Open, Michael F. Holick, PhD, MD, professor of medicine, pharmacology, physiology & biophysics and molecular medicine at Boston University Chobanian & Avedisi...

- Continued Commercial Momentum Within Core Cannabinoid Markets - Clever Leaves Holdings Inc.

Rafael Mendes, Chief Compliance Officer at Novonor (former Odebrecht), talks about the initiatives the company implemented in the last years to transform its governance. He also discussed the compliance events Novonor is leading with other organizations

In recent years – and notwithstanding encouraging windows of progress – economic difficulties, political shifts, and the pandemic's lingering effects have undercut anti-corruption efforts in Latin America.